Characteristics | SMALND (n=30) | Control (n=57) | P |
---|---|---|---|
Age, years, mean±SD | 43.7±7.7 | 45.2±8.4 | 0.390 |
BMI, kg/m2, mean±SD | 22.2±2.0 | 21.8±2.7 | 0.477 |
Stage, n (%) | Â | Â | 0.555 |
 I | 17 (56.7) | 36 (63.2) |  |
 II | 13 (43.3) | 21 (36.8) |  |
Height, m, mean±SD | 1.63±0.04 | 1.63±0.04 | 0.606 |
Weight, kg, mean±SD | 58.97±6.30 | 58.02±6.01 | 0.500 |
Subtypes, n (%) | |||
 Luminal A | 4 (13.3) | 8 (14.0) | 0.928 |
 Luminal B (HER−) | 6 (20.0) | 14 (24.6%) | 0.631 |
 Luminal B (HER+) | 6 (20.0) | 16 (28.1) | 0.410 |
 HER2+ | 9 (30.0) | 8 (14.0%) | 0.074 |
 Triple negative | 5 (16.7) | 11 (19.3) | 0.873 |
ER-positive, n (%) | 16 (53.3) | 38 (66.7) | 0.223 |
PR-positive, n (%) | 16 (53.3) | 38 (66.7) | 0.223 |
HER2-positive, n (%) | 15 (50.0) | 24 (42.1) | 0.482 |